Now in #EJPC European Society of Cardiology Journals, Christian Faaborg Andersen MD MGH IM Residents 🔎s Lp(a) testing 🧪 across Mass General Brigham 2000-2023

66,937 Lp(a) assays
5.8% w/ coronary 🫀 dz had testing
⬇️ testing in women (OR 0.73), Black pts (0.58)
Testing more common *after* CHD dx
👇
academic.oup.com/eurjpc/advance…

Spaced repetition on the go🔥

Love this idea from the superb Richard Ferraro

I’ll start with the overview and recommendations regarding Lp(a) as a risk factor #KnowLpa National Lipid Association

Incredible experience presenting at my first ACC conference. Big thanks to Michael Honigberg, MD, MPP for sponsoring!

Christian Faaborg Andersen MD MGH IM Residents presenting data on trends/disparities in Lp(a) testing 🧪 in the MGB system from 2000-present at #ACC24 American College of Cardiology
▪️Testing rates low across the study period but ⬆️ing since 2020
▪️Women and Black patients less likely to be tested
Paper coming soon!

Welcome to our incredible incoming intern class of 2024!! We are so excited for this amazing group of doctors to join us this summer 🥳🎉

An absolute clinic on #GLP1

Dr. Darren McGuire discusses uses, side effects, and the data at large. Can't imagine a better discussion from someone with true mastery of the subject. Crucial knowledge for @Cardionerds and providers across #MedTwitter !

open.spotify.com/show/4yPx76aS9…

High HDL is NOT protective in women: Our study from the #WISE study, led by our amazing fellow Sachini Ranasinghe demonstrates this U shaped curve
#HDL #women #lipids
See our paper in American Heart Journal Plus
sciencedirect.com/science/articl…

Very thought-provoking paper that builds on a lot of progress in the field of imaging and preventive cardiology

acpjournals.org/doi/10.7326/M2…

In a propensity matched cohort, aspirin use was associated with a 46% lower risk for coronary heart disease events in participants with Lp(a) >50 mg/dL without baseline #CVD . #AHAJournals Harpreet Bhatia Sam Tsimikas, MD UC San Diego Cardiology ahajrnls.org/3uMhHeN

A must read from the incredible Rachel Goodman ! CardioNerds

👀New episode alert! Join CardioNerds discuss the impact of obesity on cardiovascular disease risk. Special guest Dr. Jaime Almandoz, MD MBA FTOS shares insights on effective counseling strategies and more!

354. Obesity: Obesity & Cardiovascular Disease Risk with Dr. Jaime Almandoz

🔍 Insights from Western Denmark Heart Registry reveal a nuanced impact of LDL-C based on atherosclerosis presence.
🫀Among 23,132 CCTA patients, LDL-C lacks predictive power for future CVD when CAC=0, but strongly correlates with events in CAC>0 cases.
ahajournals.org/doi/10.1161/CI…

On your next 🏃‍♂️or🚗, take a listen to our deep dive into the ever-popular GLP-1s with expert cardio-metabolic aficionado Dr. Dennis Bruemmer. Clinical pereles galore!

And while your at it, check out tonight's CardioNerds Journal Club on the SELECT trial at 8:00 PM EST

HUGE! 💥
CRISPR for sickle cell disease & transfusion-dependent beta thalassemia approved in the UK.
This is officially the first approved CRISPR-based therapy.
Congrats to my wife & the very hard-working team Vertex Pharmaceuticals for this huge milestone in science & medicine!…

Would you ever prescribe aspirin to a patient with low risk of CVD❓❓

Watch as Dr. Melissa Tracy and Dr. Patrick Azcarate MD dive into the evidence & ESC guidelines on this topic in this bite-sized podcast.

Tune in ⬇️

cardionerds.com/341-guidelines…

A toolkit for everyone headed to the CCU ⭐️⭐️⭐️

Looking for peer mentorship, amazing supportive people, and an exciting way to learn more about Cardiology? Apply to join the CardioNerds fam!